Conexeu Sciences (NASDAQ:CNXU) Upgraded at Wall Street Zen

Conexeu Sciences (NASDAQ:CNXU) was upgraded by equities research analysts at Wall Street Zen to a “hold” rating in a research report issued to clients and investors on Saturday.

Conexeu Sciences Stock Performance

Shares of CNXU opened at $11.73 on Friday. Conexeu Sciences has a fifty-two week low of $10.87 and a fifty-two week high of $17.50.

About Conexeu Sciences

Conexeu is a company focused on building a new class of collagen-based regenerative tissue products. The Company was incorporated on November 2, 2022 under the Business Corporations Act (British Columbia) and was continued out of British Columbia and domesticated into the State of Nevada under the laws of the State of Nevada on April 10, 2025. — Conexeu is an early-stage medical device company formed to acquire and commercialize intellectual property (“IP”) developed over more than a decade at the University of British Columbia (the “University”) and the BC Professional Firefighters Burn and Wound Healing Laboratory.